EDP Sciences logo
Open Access
Ann Toxicol Anal
Volume 21, Numéro 4, 2009
Page(s) 197 - 202
DOI https://doi.org/10.1051/ata/2009058
Publié en ligne 17 décembre 2009
  1. Tunbridge R. Conclusions and recommendations of the seminar Pompidou Group. In: Road Traffic and Psychoactive Substances. Strasbourg: Council of Europe Publishing 2004: 377–378. [Google Scholar]
  2. Krüger HP, Bud Perrine MW, Mettke M, Huessy FB. Illicit drugs in road traffic. Overview of the legal provisions, difficulties faced by police, and analysis of prevention attempts in selected European countries, P-PG/Circrout (98) 4 rev. Council of Europe, Pompidou Group. Strasbourg: 1999: 1–29. [Google Scholar]
  3. Verstraete A. Oral fluid testing for driving under the influence of drugs. History, recent progress and remaining challenges. Forensic Sci Int. 2005; 150(2-3): 143–150. [CrossRef] [PubMed] [Google Scholar]
  4. Maes V, Charlier C, Grenez O, Verstaete A. Drugs and medicines that are suspected to have a detrimental impact on road user performance, in: Verstraete A (Project coordinator), ROSITA: Roadside Testing Assessment, Ghent University, Ghent, Belgium 2000: 5–44 (ROSITA Contract No. DGVII PL 98-3032). [Google Scholar]
  5. Höld M, de Boer D, Zuidema J, Maes R. Saliva as an analytical tool in toxicology. Int J Drug Testing. 1996; 1: 1–36. [Google Scholar]
  6. Mandel ID. The diagnosis use of saliva. J Oral Pathol Med. 1990; 19: 119–125. [CrossRef] [PubMed] [Google Scholar]
  7. Gorodischer R, Koren G. Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring. Dev Pharmacol Ther. 1992; 19: 161–168. [PubMed] [Google Scholar]
  8. Kaufman E, Lamster I. The diagnostic applications of saliva – a review. Crit Rev Oral Biol Med. 2002; 13: 197–202. [CrossRef] [PubMed] [Google Scholar]
  9. Haeckel R. Factors influencing the saliva/plasma ratio of drugs. Ann N Y Acad Sci. 1993; 694: 128–142. [CrossRef] [PubMed] [Google Scholar]
  10. Leute R, Ullman E, Golstein A. Inmunoassay of opiate narcotics in urine and saliva. J Am Med Assoc. 1972; 221: 1231–1234. [CrossRef] [PubMed] [Google Scholar]
  11. Peel H, Perrigo B, Mikhael N. Detection of drugs in saliva of impaired drivers. J Forensic Sci. 1984; 29: 185–189. [PubMed] [Google Scholar]
  12. Wals J, Flegel R, Crouch D, Cangianelli L, Baudys J. An evaluation of rapid point of collection oral fluid drugs-testing devices. J Anal Toxicol. 2003; 27(7): 429–439. [CrossRef] [PubMed] [Google Scholar]
  13. (a) Möller M, Steinmeyer S, Aberl F. Deliverable D3: Operational, user and legal requirements across EU members states for roadside drug testing equipment. In: ROSITA deliverables. Gent. ROSITA Consortium.1999; D3. (b) VerstraeteA. `Results of the Certified and Rosita projects'. In: Road traffic and psychoactive substances: basic documents, conclusions and recommendations – Report on the seminar in September 2003, p. 323, Pompidou Group, Strasbourg. (c) Verstraete A and Raes E (2006), `Rosita-2 project: final report' (available from www.rosita.org). [Google Scholar]
  14. Campora P. La espectrometría de masas por impacto electrónico e ionización química en el análisis de drogas de abuso en saliva. Tesis Doctoral 2001. Universidad de Santiago de Compostela. Facultad de Medicina. Instituto de Medicina Legal. [Google Scholar]
  15. Observatorio Español de Drogas. Informe nFormula 6. Plan nacional de Drogas. Ministerio de Sanidad 2003. [Google Scholar]
  16. Starner G, Mascord D, Tattam B, Zeleny R. Analysis for drugs in saliva. CR 141 Australian government publishing service. Canberra 1994: 1-76. [Google Scholar]
  17. Krugger HP, Shcultz E, Magerl H. The German roadside survey 1992-1994. Saliva analyses from an unselected driver population : licit and illicit drugs. In: Kloeden CN, Wada AJ, McLean A (Eds). Alcohol, Drugs and safety- T 95NHMRC Road accident research unit. Adelaide: University of Adelaide 1995: 55–62. [Google Scholar]